|
JP2017200928A
|
|
Sirna and use thereof in method and composition for treatment and/or prevention of eye conditions
|
|
CA2997648A1
|
|
Sirna and their use in methods and compositions for inhibiting the expression of the nrarp gene
|
|
WO2017042239A1
|
|
siRNA and their use in methods and compositions for inhibiting the expression of the CHI3L1 gene
|
|
US2017058279A1
|
|
SiRNAs and their use in methods and compositions for the treatment and/or prevention of eye conditions
|
|
EP2865757A1
|
|
siRNA and their use in methods and compositions for inhibiting the expression of the PDK1 gene.
|
|
EP2865756A1
|
|
siRNA and their use in methods and compositions for inhibiting the expression of the FLAP gene.
|
|
EP2865758A1
|
|
siRNA and their use in methods and compositions for inhibiting the expression of the ORAI1 gene
|
|
BR112015004452A2
|
|
sirna and its use in methods and compositions for the treatment and / or prevention of eye conditions
|
|
GB201215857D0
|
|
siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions
|
|
GB0910723D0
|
|
Novel drugs for inhibition of gene expression
|
|
EP1789551A2
|
|
Methods and compositions to inhibit p2x7 receptor expression
|
|
AU2005276245A1
|
|
Treatment of eye disorders characterized by an elevated introacular pressure by siRNAs
|
